Finance

Lists
Q3 2026 earnings • in 4 days
See details
LABS:TSE
Medipharm Labs Corp
CA$0.060
0.00%
(0.00) 1D
Nov 6, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LABS...
Open
CA$0.06
High
CA$0.06
Low
CA$0.06
Mkt. cap
25.84M
Avg. vol.
127.61K
Volume
80.37K
52-wk high
CA$0.10
52-wk low
CA$0.06
EPS
-CA$0.01
Beta
0.47
Shares outstanding
427.18M
No. of employees
127
Open
CA$0.06
High
CA$0.06
Low
CA$0.06
Mkt. cap
25.84M
Avg. vol.
127.61K
Volume
80.37K
52-wk high
CA$0.10
52-wk low
CA$0.06
EPS
-CA$0.01
Beta
0.47
Shares outstanding
427.18M
No. of employees
127
News stories
From web sources and news partners
About Medipharm Labs Corp
CEO-
Employees127
Founded2015
HeadquartersBarrie, Ontario, Canada
SectorHealth Care
IndustryPharmaceutical industry
Websitemedipharmlabs.com
Next call in 4 days
Thu, Nov 12, 5:00 PM
Fiscal period
Q3 2026
- / -
Revenue / Est. (CAD)
- / 10.18M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
11.45M
11.06M
8.96M
9.98M
Cost of goods sold
8.90M
7.26M
5.65M
5.56M
Cost of revenue
8.90M
7.26M
5.65M
5.56M
Research and development expenses
47.00K
52.00K
24.00K
83.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.50M
4.40M
4.28M
3.93M
Operating expense
4.74M
4.77M
4.30M
4.35M
Total operating expenses
13.64M
12.03M
9.96M
9.90M
Operating income
-2.19M
-967.00K
-994.00K
82.00K
Other non operating income
-
-
-
-
EBT including unusual items
-2.14M
-1.97M
-867.00K
4.00K
EBT excluding unusual items
-2.14M
-965.00K
-867.00K
120.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
189.00K
358.00K
-2.00K
-110.00K
Net income
-2.14M
-1.97M
-867.00K
4.00K
Net profit margin
-18.71%
-17.79%
-9.67%
0.04%
Earnings per share
-
-
-
-
Interest and investment income
62.00K
58.00K
60.00K
50.00K
Interest expense
-16.00K
-19.00K
-15.00K
-12.00K
Net interest expenses
46.00K
39.00K
45.00K
38.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.78M
-580.00K
-621.00K
458.00K
Gain or loss from assets sale
181.00K
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps